
Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa
Conlon, Thomas J., Deng, Wen-Tao, Erger, Kirsten, Cossette, Travis, Pang, Ji-jing, Ryals, Renee, Clément, Nathalie, Cleaver, Brian, McDoom, Issam, Boye, Shannon E., Peden, Marc C., Sherwood, Mark B.,Volume:
24
Journal:
Human Gene Therapy Clinical Development
DOI:
10.1089/humc.2013.037
Date:
March, 2013
Fichier:
PDF, 249 KB
2013